Supreme Court Shuts Down 'Skinny Label' Drug Patent Suit
By Ryan Davis · June 4, 2026, 10:23 AM EDT
The U.S. Supreme Court on Thursday ended a patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, saying Amarin Pharma Inc....
To view the full article, register now.